Portage Biotech Inc.
NASDAQ:PRTG
Overview | Financials
Company Name | Portage Biotech Inc. |
Symbol | PRTG |
Currency | USD |
Price | 5.15 |
Market Cap | 5,773,454 |
Dividend Yield | 0% |
52-week-range | 2.1 - 27.8 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Ian B. Walters M.B.A., M.D. |
Website | https://www.portagebiotech.com |
An error occurred while fetching data.
About Portage Biotech Inc.
Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a small molecule
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD